Articles
July 14, 2026
When To Conduct GMP Versus Non-GMP Stability Studies — And Why Both Matter
May 26, 2026
Advancing Nucleic Acid Therapeutics: LNP-Based mRNA Drug Products
May 12, 2026
Optimizing Biologics Development: A Technical Blueprint for Commercial Success
Publications
April 30, 2026
Optimizing LOD/LOQ and sample consumption during analytical ultracentrifugation to characterize AAV gene therapy vectors
Events
Colorado Protein Stability Conference
August 3–6, 2026 Breckenridge, CO, USA
CPHI Worldwide 2026
October 6-8, 2026 Milan, Italy
On-Demand Webinars
Developability Assessment and Early Formulation Studies for Biologics
Characterize Your Biologics with Smart and Science-driven Concepts
News
New Article: When To Conduct GMP Versus Non-GMP Stability Studies
April 23, 2026
Registration to ‘Characterize Your Biologics with Smart and Science-driven Concepts’ webinar is now open
April 9, 2026
Invite to networking reception in Boston
Press Releases
March 11, 2026
Coriolis Pharma US Inc. Launches Operations in North Carolina
INFOGRAPHIC
A guide for early and late-stage development, commercialization, and lifecycle management